EDGAR Filing Documents for 0001104659-15-047582

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001104659-15-047582

Filing Date

2015-06-25

Accepted

2015-06-25 12:18:08

Documents

Effectiveness Date

2015-06-25

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	a15-14497_1s8.htm	S-8	131498
2	EX-4.1	a15-14497_1ex4d1.htm	EX-4.1	37661
3	EX-4.4	a15-14497_1ex4d4.htm	EX-4.4	179432
4	EX-4.5	a15-14497_1ex4d5.htm	EX-4.5	65594
5	EX-4.6	a15-14497_1ex4d6.htm	EX-4.6	59187
6	EX-4.7	a15-14497_1ex4d7.htm	EX-4.7	75626
7	EX-4.9	a15-14497_1ex4d9.htm	EX-4.9	114854
8	EX-5.1	a15-14497_1ex5d1.htm	EX-5.1	10410
9	EX-23.2	a15-14497_1ex23d2.htm	EX-23.2	2792
10	GRAPHIC	g144971kii001.jpg	GRAPHIC	2959
	Complete submission text file	0001104659-15-047582.txt		682374

Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301

Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700

Nivalis Therapeutics, Inc. (Filer) CIK: 0001626199 (see all company filings)